Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/86359
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug |
Autor: | Vega, María Celeste; Rolón, M.; Montero-Torres, Alina; Fonseca-Berzal, Cristina; Escario, José Antonio; Gómez-Barrio, Alicia; Gálvez, J.; Marrero-Ponce, Yovani; Arán, Vicente J. CSIC ORCID | Fecha de publicación: | 2012 | Editor: | Elsevier | Citación: | European Journal of Medicinal Chemistry 58: 214- 227 (2012) | Resumen: | Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3- ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22-32, 34-38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22-24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. © 2012 Elsevier Masson SAS. All rights reserved. | URI: | http://hdl.handle.net/10261/86359 | DOI: | 10.1016/j.ejmech.2012.10.009 | Identificadores: | doi: 10.1016/j.ejmech.2012.10.009 issn: 0223-5234 e-issn: 1768-3254 |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
48
checked on 22-mar-2024
WEB OF SCIENCETM
Citations
48
checked on 24-feb-2024
Page view(s)
374
checked on 27-mar-2024
Download(s)
141
checked on 27-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.